The device company also reported a 2.9 percent increase in net sales to $2.11 billion, up 2.7 percent from the previous year. Sales related to their neurology and spine business lines saw the greatest growth, increasing 12 percent from the previous year.
More Articles on Stryker:
Stryker Recalls Two Metal Hip Implants
43 Orthopedic & Spine Devices Receive FDA Clearance in May
10 Spine Device Company Executive Moves
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.